Product name:Olaparib
CAS:763113-22-0
Molecular Formula:C24H23FN4O3
Formula Weight:435.08g/mol
Description:It is an inhibitor of PARP, an enzyme involved in DNA repair.[1] It acts against cancers in people with hereditary BRCA1 or BRCA2 mutations, which includes many ovarian, breast and prostate cancers. Early (Phase I) trials have been promising, and it is now in Phase II trials, but is not clinically approved.